TOULOUSE, France

Fabien Guilloton

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fabien Guilloton: Innovator in Adipocyte Research

Introduction

Fabien Guilloton is a notable inventor based in Toulouse, France. He has made significant contributions to the field of biotechnology, particularly in the area of adipocyte research. His innovative work focuses on the production of brown and beige adipocytes, which are crucial for understanding metabolic processes and potential therapeutic applications.

Latest Patents

Guilloton holds a patent titled "Method for obtaining human brown/beige adipocytes." This invention outlines a method for producing brown and beige adipocytes from white adipose tissue cells and mesenchymal stem cells, specifically from subcutaneous white adipose tissue cells. The patent emphasizes the use of these adipocytes in cell-based therapies and screening platforms, showcasing their potential in medical applications.

Career Highlights

Throughout his career, Fabien Guilloton has worked with esteemed organizations such as Etablissement Francais Du Sang and the Institut National De La Santé Et De La Recherche Médicale. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Guilloton has collaborated with Sandra Muller, enhancing the scope of his research and innovation. Their partnership has been instrumental in advancing the understanding of adipocyte biology and its implications for health.

Conclusion

Fabien Guilloton's work in the field of adipocyte research exemplifies the impact of innovative thinking in biotechnology. His patent and collaborations highlight the importance of developing new methods for therapeutic applications. His contributions continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…